Both in Diagnostics
Immucell vs Insight Molecular Diagnostics
Over the past year ICCC returned +60.8% and IMDX returned +4.6%; their daily moves had a correlation of 0.04.
ICCC +60.8% IMDX +4.6%Growth of $1, one year, split-adjusted
| Metric | ICCC | IMDX |
|---|---|---|
| Price | $9.94 | $3.38 |
| Market cap | $90.3M | $110.6M |
| Today | +0.61% | +6.29% |
| 1 month | 0.0% | −18.2% |
| 6 months | +54.6% | +32.5% |
| Year to date | +61.6% | −54.9% |
| 1 year | +64.8% | +1.5% |
| Revenue growth (YoY) | +11.5% | −53.9% |
| Gross margin | 33.9% | 65.7% |
| Net margin | 25.5% | −4711.3% |
| P/E (TTM) | 114.7× | — |
| Price / sales | 2.9× | 66.2× |
| Net cash | $557.3K | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 94.6% |
| Short % of float | 0.3% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).